drugset / Trial / NCT07254871
Study of DM-101PX in Adults With Birch Pollen Allergy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, double-blind placebo-controlled phase 2 trial with the aim to investigate safety and efficacy of DM-101-PX in reducing allergic symptoms provoked by nasal allergen challenge in birch pollen allergic adults. Expanded access to the study treatment is not available.
Timeline
- Start
- 2025-09-26
- Primary completion
- 2026-04-15
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DM-101PX | Unknown | — | Subcutaneous |
Indications
No indication recorded.